Abstract: To investigate the effects of the histone deacetylase inhibitor LBH589 on the osteogenic differentiation of stem cells from the apical papilla (SCAPs) in vitro. Mesenchymal stem cells were isolated from the apical papilla with patient consent. MTT assays and flow cytometric analysis of annexin V were performed to evaluate the effect of LBH589 on the proliferation and apoptosis of the SCAPs. SCAPs were cultured in osteogenic conditioned alpha minimum essential medium ( -MEM). After stimulation with different concentrations of LBH589, alkaline phosphatase staining, alkaline phosphatase activity analysis, and alizarin red staining were performed to detect the osteogenic effects of LBH589. In our in vitro study, cells treated with LBH589 showed significantly enhanced alkaline phosphatase staining, alkaline phosphatase activity, and calcium nodule formation. This study demonstrated that, as a global histone deacetylase inhibitor, LBH589 has the potential to promote the osteogenic and dentinogenic differentiation of stem cells from the apical papilla.
Introduction
Recently, mesenchymal stem cells were isolated from dental and craniofacial tissues [1] [2] [3] . These post-natal stem cells shared similar biological characteristics with bone marrow stem cells and were shown to play a significant role in tissue regeneration and cell therapy [4] [5] . Stem cells from the apical papilla (SCAPs) are pericytes that are located in the apical papilla in developing roots and are defined as mesenchymal stem cells due to their clonogenic, self-renewal and multiple differentiation potential 6) . Numerous studies have demonstrated that SCAPs may play a role in osteogenesis and dentinogenesis and have indicated that SCAPs could be a good cell resource for oral and maxillofacial tissue regeneration [7] [8] [9] . However, before SCAPs can be clinically applied in tissue regeneration, several aspects must be considered, including their limited cell number (need to be expanded in vitro) and the aging of adult stem cells (which causes the gradual loss of their differentiation potential) 2) . Thus, how molecular modifications of mesenchymal stem cells promote their proliferation and differentiation remains largely unknown.
Numerous studies have indicated that epigenetic modifications play an important role in stem cell differentiation and cell aging.
During the course of differentiation into other cell types, certain genes responsible for cell differentiation are transcribed. These molecular signals can be activated by epigenetic mechanisms in concert with the expression of differential transcription factors [10] [11] . Among several epigenetic mechanisms, including DNA methylation and histone modifications, histone acetylation and deacetylation have been shown to play pivotal roles in bone development and osteoblast differentiation. Histone deacetylase 6 (HDAC6), a co-repressor of transcription factor runx2 in the nucleus of osteoblast precursors, was found to inhibit gene transcription of p21 in osteoblasts 12) . As a global inhibitor of histone deacetylases, trichostatin A (TSA) has been shown to elevate the transcriptional activity of runx2 and, consequently, to initiate downstream gene transcription, eventually promoting osteoblast progenitor differentiation by inhibiting the activation of histone deacetylase 6. Jin et al. reported that the histone deacetylase inhibitor TSA enhanced the efficiency of odontoblast differentiation in dental pulp stem cells (DPSCs) 13) .
However, the effects of HDAC inhibitors on the differentiation of SCAPs remain unclear. In this study, we investigated the effects of LBH589 (a new global HDAC inhibitor) on the cell proliferation and osteo/odontogenic differentiation in SCAPs.
Materials and Methods

Cell culture
Tooth tissues were obtained under approved guidelines set by the Tianjin Medical University School of Stomatology with informed patient consent. Wisdom teeth or first premolars were disinfected with 75 % ethanol and then washed with phosphatebuffered saline. SCAPs were gently separated from the apical papilla of the root and then digested in a solution of 3 mg/mL collagenase type I (Sigma-Aldrich, USA) and 4 mg/mL dispase (Sigma-Aldrich, USA). The mixture was placed in a 37 °C water bath to digest for 40 to 60 minutes and shaken once every 5-10 minutes. Single-cell suspensions were obtained by passing the cells through a 70 μm strainer. MSCs were grown in a humidified, 5 % CO 2 incubator at 37 °C in α-MEM medium (Hyclone, USA) supplemented with 20% fetal bovine serum (FBS; Gibco, USA), 2 mmol/L glutamine, 100 U/ml penicillin, and 100 μg/ml streptomycin (Gibco, USA). The culture medium was changed every 2-3 days. When the fused cells had grown to 80% confluence, the cells were digested with 0.25 % trypsin containing 0.02 % EDTA for approximately 1 minute, then centrifuged at 1000 rpm for 10 min. The supernatant was discarded. The cells were seeded in culture flasks and passaged at 1:3. Cell growth was observed daily under an inverted microscope, and cell morphology and growth conditions were recorded and photographed.
Osteogenic induction
To induce the odontogenic/osteogenic differentiation of MSCs, the cells (2×10 3 /cm 2 ) were seeded in 6-well plates, grown to 80 % confluence, and then incubated in differentiation medium containing 10 nM dexamethasone, 10 mM β-glycerophosphate, 50 mg/ml ascorbate phosphate, and 10 % FBS. LBH589 at 0, 20, 50 and 100 nM was added separately to α-MEM in the experimental group, and DMSO was added to the control. The medium was changed every 2 days. After 1, 2, and 3 weeks, ALP activity, ALP staining, ARS staining and real-time PCR were performed as described below.
ALP activity assay, ALP staining and alizarin red staining
MSCs were grown in mineralization-inducing medium. For ALP, the cells were cultured for 7 days, washed twice with PBS, and fixed with medium containing 66 % acetone, 25.5 % citrate and 8.5 % formaldehyde. We discarded the medium, and the cells were washed twice with distilled water; 2 ml of ALP staining liquid was added at room temperature for 15 min, and the cells were viewed using a microscope. After cultured for 3, 5, and 7 days, the cells were washed twice with PBS, 300 μL of lysis buffer was added for 15 min, and then the supernatant was collected.
Then, 100 μl of mixer (50 μl ALP buffer solution, 50 μL stock substrate Sol) was added to 10 μL of the supernatant at 37 C for 15 min, then the stop solution was added, and the absorbance was measured at 450 nm. To detect mineralization, the cells were induced for 2-3 weeks, fixed with 70 % ethanol, and stained with 40 mM alizarin red S (Sigma-Aldrich, USA) dissolved in distilled water for 5 min, washed with distilled water, and observed using a microscope. To quantitatively determine the concentration of calcium, alizarin red was destained with 10 % cetylpyridinium chloride in 10 mM sodium phosphate for 30 min at room temperature. The concentration was determined by measuring the absorbance at 562 nm on a multiplate reader and comparing the results to a standard calcium curve prepared with calcium dilutions in the same solution. The final calcium level in each group was normalized to the total protein concentration detected in a duplicate plate.
Cell proliferation assay
The proliferation of SCAPs was examined using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, which evaluates the levels of mitochondrial succinic dehydrogenase in proliferating cells. MTT is reduced to an insoluble purple formazan reaction product, which can be determined quantitatively by a colorimetric assay. Briefly, cells were cultured in 96-well plates at an initial density of 8×10 3 cells
per well in α-MEM and then serum-starved for 12 hours. LBH589
at concentrations of 0, 10, 20, 50, 100, 200, and 500 nM was added separately to α-MEM medium in the experimental group, whereas the control was untreated. After 2 days of culture, the cells were treated with 10 μl of MTT reagent and incubated at 37°C for 4 hours. The medium was aspirated, and the cells were washed twice with PBS followed by treatment with dimethyl sulfoxide. The absorbance was read at 490 nm with an automatic enzyme-linked immunosorbent assay reader.
Annexin V flow cytometry analysis of cell apoptosis
To identify the putative SCAP stem cells, the fourth generation of isolated SCAP cells was seeded in 6-well plates, grown to 80 % confluence, and then LBH589 at concentrations of 0, 10, 20, 50, 100, 200, 500 and 1000 M was added separately to α-MEM medium in the experimental group for 8 hours. Flow cytometry analysis of cell apoptosis was performed with an annexin V apoptosis kit according to the manufacturer's instructions (Invitrogen, USA).
Statistics
All statistical calculations were performed using SPSS13.0 statistical software. Student's t-test or one-way ANOVA was performed to determine statistical significance. A P-value < 0.05 was considered significant. 
Results
SCAPs showed similar properties with bone marrow mesenchymal stem cells in biomarkers, colony-forming units and multiple differentiation potentials
Mesenchymal stem cells were isolated from human dental apical papilla using previously described standardized methods and were enzymatically expanded. STRO-1, CD90 (Thy-1), and CD146 were expressed in SCAPs according to flow cytometric analysis, and SCAPs showed colony-forming properties and osteoblast and adipose differentiation potential, as reported previously (data not shown) 3) .
LBH589 affected the proliferation of SCAPs in a dose-dependent manner
Several studies reported that histone deacetylase inhibitors regulate the cell cycle in a variety of cell lineages. Here, we first tested the effects of LHB589 on the proliferation of SCAPs using an MTT assay. After incubation with MTT for 4 hours, the OD values decreased gradually in cells stimulated with 10, 20, 50, 100, and 500 nM LBH589 (Fig. 1, P<0 .01, n=5), which indicated that LBH589 inhibited the proliferation of SCAPs in a dosedependent manner.
LBH589 enhanced the apoptosis of SCAPs in a dose-dependent manner
To investigate this substance with promise in tissue regeneration, we next tested the effects of LBH589 on apoptosis in SCAPs. As an early marker of apoptosis, annexin V was added to the culture medium and the cells were then analyzed using flow cytometry. When compared with DMSO as a control, SCAPs stimulated with increasing concentrations of LBH589 displayed gradually increasing annexin V-positive proportions. A significantly higher number of apoptotic cells were found in SCAPs treated with 1000 nM LBH589 than in SCAPs treated with 10, 20, 50, 100, 200, 500 and 1000 nM LBH589 (Fig. 2, 
P<0.05, n=5).
In conditioned medium, LBH5and 589 enhanced the osteogenic differentiation of SCAPs
To investigate the effects of LBH589 on osteogenic differentiation in SCAPs, osteogenic conditioned medium was added to cultured SCAPs for 7 to 21 days. Based on the cell proliferation and apoptosis results, 20, 50 and 100 nM concentrations of LBH589 were selected as stimulators. After alkaline phosphatase staining, 20, 50 and 100 nM LBH589-treated SCAPs showed a significantly increased expression of ALP an early marker of osteoblast differentiation.
ALP activity was found to be significantly increased in 20, 50 and 100 nM LBH589 stimulated SCAPs compared to DMSO as a control (1.019±0.029 vs. 1.540±0.034 vs. 1.560±0.045 vs. 0.760±0.028, respectively; P <0.01, n=5; Fig. 3 ).
After culturing the cells in osteogenic conditioned medium for 21 days, alizarin red staining (AR-S) was performed to examine mineralized nodule formation. Similarly to ALP staining, SCAPs treated with 20, 50 and 100 nM LBH589 exhibited significantly increased AR-S staining. To quantitatively assess calcium mineral density, 10 % cetylpyridinium chloride (Sigma, USA) in 10 mM sodium phosphate was added for 30 min at room temperature to destain the alizarin red. The UV absorbance results showed that the calcium concentration was significantly elevated in SCAPs stimulated with 20, 50 and 100 nM LBH589 compared to DMSO as a control (0.921±0.027 vs. 1.241±0.027 vs. 1.653±0.024 vs. repair, cellular apoptosis, angiogenesis, tumor invasion and metastasis [14] [15] . In this study, we found that LBH589 enhanced both the alkaline phosphatase activity and the alkaline phosphatase expression of SCAPs in vitro. Furthermore, LBH589 increased calcium nodule formation during the osteo/odontogenic differentiation of SCAPs. These results confirmed that histone deacetylase inhibitor LBH589 has an obvious role in promoting the osteo/odontogenic differentiation of SCAPs. These results
showed that an HDAC inhibitor had the same effects on SCAPs as those reported by Jin et al. on DPSCs 13) .
Previous studies have shown that, as a new type of broadspectrum histone deacetylase inhibitor, LBH589 could suppress histone deacetylases 1, 2, 3, 5, 6, 9 and 10 at a low concentration. However, further studies will be needed to confirm the effects of LBH589 in the directed differentiation of mesenchymal stem cells in vitro.
The epigenetic modifications of histones have a large role in the process of regulating gene transcription and are important regulatory factors in mesenchymal stem cell differentiation. In a BCOR mutation family (oculo-facio-cardio-dental syndrome, OFCD), SCAPs have been shown to exhibit abnormally elevated levels of proliferation and differentiation. Investigation of the mechanism revealed that FBXL10 (a histone demethylase) lost the ability to inhibit osteo/dentinogenic differentiation in these MSCs by failing to form a complex with BCOR, thereby resulting in increased H3K4 trimethylation and H3K36 dimethylation on a target gene promoter and activating AP-2a, the transcription factor of osteo/dentinogenic differentiation 7) . Ye et al. found that KDM4B and KDM6B regulate critical osteogenic genes, including HOX and DLX, by removing a methyl group from H3K9me3 and H3K27me3 in target genes in mesenchymal stem cells and therefore regulate the osteogenic differentiation of stem cells 17) .
Acetylation is another epigenetic modification that is regulated by histone acetyl-transferases (HATs) and histone deacetylases (HDACs), both of which play vital roles in genetic transcription regulation. HATs and HDACs participate in a variety of physiological and pathological processes. HDACs also have a direct modification effect on nonhistone transcription factors, such as p53, ku70, pRB and E2F-1. HDACs are zinc-dependent proteins 18) . Baltus et al. showed that Nanog is vital in maintaining .
SCAPs are important sources of cells involved in root development. The root development process of young permanent teeth is often destroyed by developmental defects, trauma, and caries. Apexification is commonly used to treat these conditions. In this study, although certain concentrations (20, 50, 100 nM) of LBH589 had a mild effect on the proliferation and apoptosis of SCAPs, LBH589 could effectively promote odontogenic differentiation of SCAPs at these same concentrations, which may provide a new drug option for apexification. Meanwhile, future studies should focus on the prospective application of LBH589 in oral and maxillofacial bone tissue regeneration. Nevertheless, the molecular mechanism of HDAC inhibitors in promoting the differentiation of mesenchymal stem cells remains unclear. The efficacy and safety of the clinical application of LBH598 also requires further research.
